Clark E S, Granger D N
Department of Physiology, University of South Alabama, Mobile.
J Pharmacol Exp Ther. 1988 Mar;244(3):983-6.
Experiments were performed to evaluate the effects of the specific dopamine-1-receptor agonist, fenoldopam, on the feline intestinal microcirculation. Cranial mesenteric arterial pressure, cranial mesenteric vein pressure, cranial mesenteric vein blood flow, venous occlusion capillary pressure, pre- and postcapillary resistances, total mesenteric vascular resistance, lymph flow, lymph and plasma protein concentrations, the capillary osmotic reflection coefficient, and the capillary filtration coefficient were determined in an isolated autoperfused jejunal segment in anesthetized fasted cats during intra-arterial administration of saline or fenoldopam mesylate in saline. Fenoldopam significantly increased mean cranial mesenteric vein blood flow from 26.8 +/- 3.4 to 33.7 +/- 2.8 ml.min-1.100 g-1. This increase in blood flow was due primarily to a significant decrease in mean intestinal vascular resistance from 3.14 +/- 0.32 to 2.54 +/- 0.2 mm Hg.ml-1.min-1.100 g-1, since cranial mesenteric arterial pressure during fenoldopam infusion was not different from the value obtained during control studies. Mean capillary pressure during fenoldopam infusion (17.2 +/- 0.5 mm Hg) was significantly greater than mean capillary pressure during control studies (15.6 +/- 0.3 mm Hg). The mean lymph flow during fenoldopam infusion (0.186 +/- 0.083 g/dl) was significantly greater than the value obtained during saline infusion (0.08 +/- 0.009 g/dl). Fenoldopam infusion significantly increased the mean capillary filtration coefficient from 0.135 +/- 0.021 to 0.275 +/- 0.035 ml.min-1.100 g-1.mm Hg-1 without altering the capillary osmotic reflection coefficient. These results suggest that specific dopamine-1-receptor stimulation in the small intestine increases the perfused capillary density without altering capillary permeability.(ABSTRACT TRUNCATED AT 250 WORDS)
进行实验以评估特异性多巴胺 -1- 受体激动剂非诺多泮对猫肠道微循环的影响。在麻醉的禁食猫的离体自体灌注空肠段中,在动脉内注射生理盐水或甲磺酸非诺多泮期间,测定肠系膜上动脉压、肠系膜上静脉压、肠系膜上静脉血流量、静脉闭塞毛细血管压、毛细血管前和后阻力、总肠系膜血管阻力、淋巴流量、淋巴和血浆蛋白浓度、毛细血管渗透反射系数以及毛细血管滤过系数。非诺多泮使肠系膜上静脉平均血流量从 26.8±3.4 显著增加至 33.7±2.8 ml·min⁻¹·100 g⁻¹。血流量的增加主要是由于平均肠道血管阻力从 3.14±0.32 显著降低至 2.54±0.2 mmHg·ml⁻¹·min⁻¹·100 g⁻¹,因为在输注非诺多泮期间肠系膜上动脉压与对照研究期间获得的值无差异。输注非诺多泮期间的平均毛细血管压(17.2±0.5 mmHg)显著高于对照研究期间的平均毛细血管压(15.6±0.3 mmHg)。输注非诺多泮期间的平均淋巴流量(0.186±0.083 g/dl)显著高于输注生理盐水期间获得的值(0.08±0.009 g/dl)。输注非诺多泮显著增加平均毛细血管滤过系数,从 0.135±0.021 增加至 0.275±0.035 ml·min⁻¹·100 g⁻¹·mmHg⁻¹,而不改变毛细血管渗透反射系数。这些结果表明,小肠中特异性多巴胺 -1- 受体刺激可增加灌注的毛细血管密度,而不改变毛细血管通透性。(摘要截断于 250 字)